Previous Article | Next Article 
Journal of Virology, April 2001, p. 3766-3770, Vol. 75, No. 8
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.8.3766-3770.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Adaptation of Influenza A Viruses to Cells
Expressing Low Levels of Sialic Acid Leads to Loss of
Neuraminidase Activity
Mark T.
Hughes,1,2
Martha
McGregor,1
Takashi
Suzuki,3
Yasuo
Suzuki,3 and
Yoshihiro
Kawaoka1,4,*
Department of Pathobiological Sciences,
School of Veterinary Medicine, University of Wisconsin
Madison,
Madison, Wisconsin 537061; Department of
Pathology, University of Tennessee
Memphis, Memphis, Tennessee
381632; and Department of Biochemistry,
University of Shizuoka, School of Pharmaceutical Sciences, Shizuoka-shi
422-8526,3 and Institute of Medical
Science, University of Tokyo, Tokyo 108-8639,4
Japan
Received 10 August 2000/Accepted 9 January 2001
 |
ABSTRACT |
Influenza A viruses possess two virion surface proteins,
hemagglutinin (HA) and neuraminidase (NA). The HA binds to
sialyloligosaccharide viral receptors, while the NA removes sialic
acids from the host cell and viral sialyloligosaccarides. Alterations
of the HA occur during adaptation of influenza viruses to new host
species, as in the 1957 and 1968 influenza pandemics. To gain a better
understanding of the contributions of the HA and possibly the NA to
this process, we generated cell lines expressing reduced levels of the
influenza virus receptor determinant, sialic acid, by selecting
Madin-Darby canine kidney cells resistant to a lectin specific for
sialic acid linked to galactose by
(2-3) or
(2-6) linkages. One
of these cell lines had less than 1/10 as much
N-acetylneuraminic acid as its parent cell line. When
serially passaged in this cell line, human H3N2 viruses lost sialidase
activity due to a large internal deletion in the NA gene, without
alteration of the HA gene. These findings indicate that NA mutations
can contribute to the adaptation of influenza A virus to new host
environments and hence may play a role in the transmission of virus
across species.
 |
INTRODUCTION |
Influenza A viruses possess two
surface spike proteins, hemagglutinin (HA) and neuraminidase (NA)
(12). The HA protein, a trimeric type I membrane protein,
is responsible for binding to sialyloligosaccharides (oligosaccharides
containing terminal sialic acid linked to galactose) on host cell
surface glycoproteins or glycolipids (reviewed in reference
28). This protein is also responsible for fusion between
viral and host cell membranes, following virion internalization by
endocytosis. Neuraminidase (NA), a tetrameric type II membrane protein,
is a sialidase that cleaves terminal sialic acid residues from the
glycoconjugates of host cells and the HA and NA and thus is recognized
as a receptor-destroying enzyme (1). This sialidase
activity is necessary for efficient release of progeny virions from the
host cell surface, as well as prevention of progeny aggregation due to
the binding activity of viral HAs with other viral glycoproteins
(18, 23). Thus, the receptor-binding activity of the HA
and the receptor-destroying activity of the NA likely act as
counterbalances, allowing efficient replication of influenza A virus.
Influenza A viruses of all known subtypes have been isolated from a
variety of animals, including humans, wild and domestic birds, pigs,
horses, and sea mammals (27). Viruses responsible for the
1957 and 1968 influenza pandemics were reassortants between human and
avian viruses with the PB1, HA, and/or NA genes derived from the latter
(10, 13, 22). Such interspecies transmission of avian
virus genes forces adaptation of the gene products to the new
environment (i.e., human respiratory organs).
Comparative studies have demonstrated that HA receptor specificity
differs among influenza A viruses, depending on the animal species from
which they were isolated (20, 21). Thus, amino acid
alterations are needed for efficient viral growth in new animal hosts.
To gain a better understanding of how influenza A viruses adapt to new
environments and thus acquire the ability to cause epidemics or
epizootics, we produced cell lines with reduced expression of terminal
sialic acid residues on the cell surface. We then passaged influenza A
viruses in this altered cellular environment and determined the
molecular basis of the subsequent growth adapation.
 |
MATERIALS AND METHODS |
Viruses and cells.
Human H3N2 viruses isolated from a single
patient, either in embryonated chicken eggs (A/Tottori/872/AM2AL3/94;
AM2AL3) or Madin-Darby canine kidney (MDCK) cells (A/Tottori/872/K4/94;
K4), were obtained from T. Ito (Tottori University, Tottori, Japan). Virus stocks were grown either in 10-day-old embryonated chicken eggs
(AM2AL3 virus) or on MDCK cells (K4 virus) in minimal essential medium
(MEM) supplemented with 0.3% bovine serum albumin and 0.5 mg of
trypsin/ml. MDCK cells were maintained in MEM supplemented with 5%
newborn calf serum (Sigma, St. Louis, Mo.).
Generation of lectin-resistant cell lines.
MDCK cells grown
to 75% confluency were washed three times with phosphate-buffered
saline and incubated with Maakia amurensis (MAA) lectin (100 mg/ml; Boehringer Mannheim, Mannheim, Germany) or Sambucus
nigra (SNA) lectin (100 mg/ml; Boehringer Mannheim) in MEM
containing 0.3% bovine serum albumin. After a 48-h incubation, the
medium was replaced with growth medium (MEM-5% fetal calf serum).
Lectin selection was repeated as above two additional times. Surviving
cell colonies were then cloned, and the SNA- and MAA-selected cell
lines were designated MDCK-Sn10 and MDCK-Ma, respectively.
Fluorometric HPLC method for determination of sialic acid
content.
The sialic acid (N-acetylneuraminic acid
[NeuAc] and N-glycolylneuraminic acid [NeuGc]) content
of both cell lines and the purified virus was determined
fluorometrically by high-performance liquid chromatography as described
previously (25). Each sample was placed in a 5-ml ground
glass-topped vial and mixed with 100 µl (25 mM) of sulfuric acid. The
vials were then heated at 60°C for 12 h to hydrolyze sialo-sugar
chains. After cooling, 50 µl of 1,2-diamino-4,5-methylene
dioxybenzene was added to 50 µl of the hydrolyte, and the mixture was
heated to 60°C for 2.5 h in the dark to develop the fluorescence
of the sialic acids. A 10-µl aliquot of the resulting solution was
then injected into an 880-PU high-performance liquid chromatograph
(JASCO, Tokyo, Japan) equipped with a sample injector valve (model
7125; Reodyne,) and a fluorescent spectrophotometer (650-105; Hitachi,
Tokyo, Japan) with a 20-µl flow cell and a recorder (Chromatopac
C-R5A; Shimadzu, Kyoto, Japan). The fluorescence spectrophotometer was
positioned at an excitation wavelength of 373 nm and an emission
wavelength of 448 nm. Standard mixtures (200 pmol/µl) of NeuAc
(Sigma) and NeuGc (Sigma) were used to establish calibration curves.
Fluorometric sialidase activity assay.
Virus sialidase
activity (5 × 102 PFU was measured with
2'-(4-methylumbelliferyl)-
-D-N-acetylneuraminic
acid (Sigma) as a substrate as described previously (6).
Briefly, the fluorogenic substrate, diluted 1:2 with 0.5 M sodium
acetate (pH 4.6), was added to an equal volume of virus samples and
incubated for 30 min at 37°C. Reactions were stopped with 200 ml of
0.5 M Na2CO3 (pH 10.7), and fluorescence was
then measured at an excitation wavelength of 360 nm and an emission
wavelength of 460 nm. All reactions were performed in duplicate.
Sequence analysis of the NA and HA genes.
Total viral RNA
(vRNA) was obtained from virus sample with use of the Qiaspin vRNA
purification kit as instructed by the manufacturer (Qiagen, Inc.,
Valencia, Calif.). For cDNA production, the oligonucleotide Uni-12,
complementary to the conserved 12 vRNA 3'-terminal nucleotides of
influenza A virus gene segments, was used as a primer for the Moloney
murine leukemia virus reverse transcriptase (Promega, Madison, Wis.)
reaction. The NA gene cDNA was amplified during 30 rounds of PCR with
the NA gene-specific primers JN2-43s (5' cRNA sense sequence:
5'-TGGCTCGTTTCTCTCACTATTGCC-3') and JN2-1410r (3' cRNA
antisense sequence, 5'-TTATATAGGCATGAGATTGATGTCCG-3') and 10 U of Pwo DNA polymerase (Boehringer Mannheim). The resulting PCR products were subcloned into the vector pCR2.1 (Invitrogen, Carlsbad, Calif.) and used for automated fluorescent sequencing. The HA
genes were cloned in a similar fashion with the HA gene-specific primers JH3-Up (5' cRNA sense primer sequence,
5'-AGCAAAAGCAGGGGATAATTCTATTAACCATGAAGAC-3') and JH3-Down
(3' cRNA antisense primer sequence,
5'-AGTAGAAACAAGGGTGTTTTTAATTAATGCACTC-3'). For each isolate,
three clones were examined to obtain the NA and HA consensus sequences.
 |
RESULTS |
Generation of lectin-resistant cell lines.
To produce cell
lines with a decreased level of sialic acid expression on the cell
surface, we used two lectins, SNA and MAA, that differ in sialic
acid-binding specificity. The MAA lectin binds to sialic acid linked to
galactose by
(2-3) linkages (26), while the SNA lectin
is specific for sialic acids linked to galactose or
N-acetylgalactosamine by
(2-6) linkages
(24). The MDCK cell line, which supports the growth of
influenza viruses, was used as a parent cell line for lectin selection.
When incubated in the presence of either lectin, the majority of cells
died within a week. Resistant cell clones were then grown out for stock
cultures. The cell lines resulting from MAA and SNA lectin selection
were designated MDCK-Ma and MDCK-Sn10, respectively.
Fluorescent-activated cell sorting (FACS) with digoxigenin-labeled MAA
and SNA lectins (Fig. 1A) demonstrated
high levels of binding of MDCK cells to both lectins, as we previously
reported (9). MDCK-Sn10 cells, selected with
(2-6)
linkage-specific lectin, retained strong binding to the
(2-3)-specific MAA lectin but showed SNA lectin binding weaker than
that of the MDCK parent. By contrast, MDCK-Ma cells, selected with the
(2-3) linkage-specific lectin, bound both lectins much more weakly
than MDCK cells.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 1.
Binding of lectins to lectin-resistant cell lines. For
each cell line, cells were incubated with digoxigenin-labeled MAA or
SNA lectins, followed by fluorescein isothiocyanate-labeled
antidigoxigenin antibody, and then analyzed by FACS. Bold lines,
binding of the MAA lectin; narrow lines, binding of the SNA lectin;
shaded profiles, negative control (no lectin added).
|
|
Viral growth in MDCK-Sn10 and MDCK-Ma cell lines.
To learn how
influenza viruses adapt to cells with reduced receptor
expression, we chose two influenza virus variants (AM2AL3 and K4)
with known sialic acid receptor linkage specificity (9). The K4 virus specifically recognizes NeuAc linked to galactose by
(2-6) linkages [NeuAc
(2-6)Gal], while the AM2AL3 virus is specific for NeuAc
(2-3)Gal. Both viruses replicated almost as well
in MDCK-Sn10 cells as in MDCK cells (Table
1). However, the titers of both viruses
in MDCK-Ma cells were 1 log lower than in MDCK cells. We also noted
that after infection with either virus, even at a multiplicity of
infection of 10, a small percentage of MDCK-Ma cells continued to
grow to confluency without any cytopathic effects. Virus production
could not be detected in these surviving cells by hemagglutination
assay upon replacement of the medium with that containing trypsin,
which promotes virus growth. The cells were also negative by
immunochemical staining for both influenza virus HA and NP proteins
(data not shown), thus demonstrating that the cells were not
persistently infected. We designated the surviving cells MaKS.
FACS analysis with both SNA and MAA lectins demonstrated that the MaKS
cells, like the MDCK-Ma cells from which they were derived, bound the
(2-6)-specific SNA lectin much more weakly than did MDCK cells (Fig.
1B). In addition, the MAA lectin-binding peak of MaKS cells was much
narrower than that of the MDCK-Ma cell line, with loss of a small
shoulder peak representing a higher MAA-binding population (Fig. 1).
To determine whether reduced amounts of sialic acid were responsible
for the reduced lectin binding of MaKS cells, we quantified the sialic
acid levels present in the MaKS cells by liquid chromatographic analysis. The MaKS cell line showed much lower levels of both NeuAc and
NeuGc (8.2 and 0.4 pmol/µg of protein, respectively) than did MDCK
cells (216.0 and 2.5 pmol/µg of protein, respectively), although the
NeuGc content was much lower. These data demonstrate an extensive
reduction of sialic acid receptor determinant in MaKS cells.
Adaptation of virus in MaKS cells.
To determine how AM2AL3 and
K4 viruses propagate and adapt to growth in cells expressing very low
levels of virus receptor, we serially passaged both viruses in MaKS
cells in liquid culture. Since both viruses replicated more poorly in
MaKS cells than in MDCK cells (Table 2),
passages 1 through 3 were performed without dilution, and passages 4 through 13 were performed at 1:1,000 dilution. After passage 8, the
diameter of plaques produced by either variant had changed from large
(greater than 3 mm) to smaller (approximately 1 mm). By passage 10 and
higher, only smaller plaques were present when the viruses were assayed
with MDCK cells (data not shown). After 13 serial passages, both
viruses were able to grow in MaKS cells as well as or better than in
MDCK cells (Table 2). Virus stocks produced from either variant after
passage 13 were amplified and designated AL3(MaKS)-13 and K4(MaKS)-13,
respectively.
Mutational analysis of the HA and NA genes of AL3 (MaKS)-13 and
K4(MaKS)-13 viruses.
To determine the molecular basis of virus
adaptation to a cellular environment characterized by a reduced
receptor concentration, we first reverse transcribed the HA genes of
the AL3(MaKS)-13 and K4(MaKS)-13 viruses, amplified the cDNAs by PCR,
and sequenced the resulting products. Neither of the genes contained
mutations by comparison with the corresponding HA genes from the two
parental viruses.
Since changes in NA sialidase activity likely influence HA
receptor-binding activity, we next determined the NA sequence of the
AL3(MaKS)-13 and K4(MaKS)-13 viruses. Sequence analysis of the NA genes
of both variants revealed large internal deletions (Fig.
2). In AL3(MaKS)-13, the deletion
extended from nucleotides 220 to 1253, shifting a reading frame and
thus generating a stop codon immediately after the deletion. The coding
capacity of this NA is 66 amino acids, corresponding to the cytoplasmic
tail, the transmembrane domain, stalk region, and a short portion of
the head region. Similarly, the K4(MaKS)-13 isolate contained a
deletion in the NA gene from bases 130 to 1193, bringing a stop codon
into frame at codon 39. Like the AL3(MaKS)-13 virus, the gene no longer encoded a full catalytic head region. Thus, viruses passaged in a cell
line with very low receptor expression lost their NA catalytic activity.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Structures of the NA genes of the AL3(MaKS)-13 and
K4(MaKS)-13 mutants. (A) The AL3(MaKS)-13 NA contains a 936-nucleotide
deletion (from bases 220 to 1253) that removes a large portion of the
NA gene coding sequence. This mutation also brings a TAG stop codon
into frame two bases beyond the deletion, so that the gene potentially
encodes only a 66-amino-acid peptide, corresponding to the cytoplasmic
tail, transmembrane region, stalk, and a portion of the NA head. (B)
The K4(MaKS)-13 NA gene contains a 1,066-nucleotide deletion (from
bases 130 to 1193) that removes a large portion of the NA gene coding
sequence. This mutation also brings a TAG stop codon into frame four
bases beyond the deletion, so that the gene potentially encodes only a
38-amino-acid peptide, corresponding to the cytoplasmic tail and
transmembrane region of the NA gene.
|
|
To confirm this result, we tested the AL3(MaKS)-13 and K4 (MaKS)-13
variants for sialidase activity, using a fluorescent sialidase substrate
[2'-(4-methylumbelliferyl)-
-D-N-acetylneuraminic
acid]. Unlike the parental viruses, neither of the NA deletion mutants had detectable sialidase activity (Fig.
3).

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 3.
Sialidase activity of the parental AM2AL3 and K4 viruses
and the AL3(MaKS)-13 and K4(MaKS)-13 mutants. For each sample, virus
(5 × 102 PFU) was incubated in duplicate for 1 h
at 37°C in the presence of a fluorogenic sialidase substrate
(4-methylumbelliferyl-a-D-N-acetylneuraminic
acid). The fluorescence of released 4-methylumbelliferone was
determined with a fluorometer (Labsystems Fluoroskan II) with
excitation at 360 nm and emission at 460 nm.
|
|
Extent of sialylation of viral glycoproteins.
During normal
infection, viruses with reduced sialidase activity fail to grow
efficiently and aggregate at the cell surface (18, 23).
Why, then, do AL3(MaKS)-13 and K4 (MaKS)-13 viruses, which lack
sialidase activity, grow in MaKS cells? One possible explanation would
be that since the sialic acid content of these cells is low, the extent
of sialylation of the HA and NA oligosaccharides may also be low,
preventing the aggregation of viruses at the infected cell surface,
even when viral sialidase activity is absent. To test this hypothesis,
we compared the sialic acid content in purified virus preparations
between AM2AL3 and K4 viruses grown in MDCK cells and AL3(MaKS)-13
virus grown in MaKS cells. The NeuAc content was similar among the
virus samples, although the AM2AL3 virus had lower sialic acid content
(0.9 pmol of NeuAc/g of protein) than the other samples
(A/Tottori/872/K4/94, 3.8 pmol of NeuAc/g of protein; AL3[MaKS]-13,
2.6 pmol of NeuAc/g of protein). Thus, viruses lacking sialidase
activity can grow efficiently in cells expressing a reduced level of
sialic acid because the viral glycoproteins are not sialylated
extensively compared with those in normal cell lines and are not bound
by the HA, thus preventing viral aggregation.
 |
DISCUSSION |
In previous studies, the passage of influenza A viruses in the
presence of an exogenous bacterial sialidase activity and antibodies to
the viral NA led to deletion of the viral NA gene (14, 15, 29). Moreover, NA mutants obtained by such passaging were able to grow in cell cultures lacking exogenous sialidase activity, as well
as in eggs and mice, as a result of compensatory mutations in the HA
protein that reduce the molecule's affinity for sialic acid residues
(8). We demonstrate here that influenza A viruses can
adapt to growth in cells with greatly reduced receptor expression by
large NA gene deletion mutations that abolish sialidase activity. Even
though the reduction of viral receptors could theoretically affect the
receptor-binding HA protein, we found that only the NA gene was altered.
What is the molecular basis of this finding? In normal cellular
environments where sialic acid receptors are abundant, the loss of NA
activity can be compensated for by reduction of the viral HA affinity
for sialic acid, allowing efficient release of progeny from the host
cell surface and preventing virion aggregation (8). In the
absence of high levels of viral receptors, as in our MaKS cells, a
reduction of HA affinity is not necessary to release viral progeny and
allow the growth of NA deletion mutants. In fact, high-affinity binding
of the HA protein must be maintained for viral replication in cells
expressing low levels of viral receptor. Sialidase activity, however,
is not required for virion release and prevention of virion aggregation
in such an environment, since the amounts of sialic acid on cell
surface molecules are quite low and the sialic acid contents of NA
deletion virions are similar to that of wild-type virions (see
Results). In fact, sialidase activity is likely deleterious for viral
growth because it further removes receptor determinant sialic acid from
the cell surface. We have recently shown that influenza A virus lacking an NA stalk, and thus unable to grow in eggs, acquired a stalk insertion of up to 22 amino acids through nonhomologous RNA-RNA recombination (16). Taken together, these finding indicate
that influenza viruses can adapt to new host environments by undergoing radical genetic changes, including large insertions and deletions.
We stress that in both this and previous studies (8, 14),
viruses lost sialidase activity by internal deletions in the NA gene
segment that spared segment ends encoding the cytoplasmic tail and
transmembrane region. Thus, the preserved regions of the NA gene in
these mutants may be necessary for functions such as virion
morphogenesis and stability, a possibility awaiting confirmation in
future studies.
MaKS cells have a lower sialic acid content than their parental (MDCK)
cells. Although similar cell lines have been produced from CHO cells
(19), they have not proven useful for influenza virus
studies because of their inability to support efficient influenza virus
replication. By contrast, MaKS cells were derived from MDCK cells, a
standard cell line in studies of influenza viruses, and should be
useful in viral receptor-based analyses. For example, since exogenously
added gangliosides are known to be incorporated into host cell
membranes (4), one could therefore incubate known
gangliosides with MaKS cells and test their ability to serve as viral receptors.
During the past century, three influenza A virus pandemics arose when
the HA or both the HA and NA genes of emerging viruses were introduced
into a human population. Comparative studies of viruses from different
host animals suggest that in these pandemic strains, mutations were
introduced in the HA gene (3). Whether similar mutations
are required in the NA to enable the virus to cross host species
barriers remains unknown; however, the substrate specificity of the
human virus N2 NA, which was derived from an avian virus, gradually
changed during its replication in humans (2). Results of
the current study indicate that NA mutations can indeed contribute to
the ability of influenza A viruses to adapt to new environments.
Support for this hypothesis comes from a study in which a reassortant
virus with a human virus NA and the remaining genes from a duck virus
failed to replicate in ducks (7), even though the NA of
the human virus originated from an avian virus (22). This
suggests that mutations likely occurred in the NA gene during
adaptation in humans. Comparative studies of viral NAs from different
animal hosts, in conjunction with recently developed plasmid-based
reverse genetics (5, 17), may yield useful insights into
how these surface glycoproteins contribute to adaptive changes among
influenza A viruses in nature.
 |
ACKNOWLEDGMENTS |
We thank Krisna Wells for excellent technical assistance and John
Gilbert for editing the manuscript.
Support for this work came from Public Health Service research grants
from the National Institute of Allergy and Infectious Diseases.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin
Madison, 2015 Linden Dr. West, Madison, WI 53706. Phone: (608) 265-4925. Fax: (608) 265-5622. E-mail:
kawaokay{at}svm.vetmed.wisc.edu.
 |
REFERENCES |
| 1.
|
Air, G. M., and W. G. Laver.
1989.
The neuraminidase of influenza virus.
Proteins Struct. Func. Genet.
6:341-356.
|
| 2.
|
Baum, L. G., and J. C. Paulson.
1991.
The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity.
Virology
180:10-15[CrossRef][Medline].
|
| 3.
|
Bean, W. J.,
M. Schell,
J. Katz,
Y. Kawaoka,
C. Naeve,
O. Gorman, and R. G. Webster.
1992.
Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts.
J. Virol.
66:1129-1138[Abstract/Free Full Text].
|
| 4.
|
Carroll, S. M., and J. C. Paulson.
1985.
Differential infection of receptor-modified host cells by receptor-specific influenza viruses.
Virus Res.
3:165-179[CrossRef][Medline].
|
| 5.
|
Fodor, E.,
L. Devenish,
O. G. Engelhardt,
P. Palese,
G. G. Brownlee, and A. Garcia-Sastre.
1999.
Rescue of influenza A virus from recombinant DNA.
J. Virol.
73:9679-9682[Abstract/Free Full Text].
|
| 6.
|
Hara, S.,
Y. Takemori,
M. Yamaguchi,
M. Nakamura, and Y. Ohkura.
1987.
Fluorometric high-performance liquid chromatography of N-acetyl- and N-glycolylneuraminic acids and its application to their microdetermination in human and animal sera, glycoproteins, and glycolipids.
Anal. Biochem.
164:138-145[CrossRef][Medline].
|
| 7.
|
Hinshaw, V. S.,
R. G. Webster,
C. W. Naeve, and B. R. Murphy.
1983.
Altered tissue tropism of human-avian reassortant influenza viruses.
Virology
128:260-263[CrossRef][Medline].
|
| 8.
|
Hughes, M. T.,
M. Matrosovich,
E. M. Rodgers,
M. McGregor, and Y. Kawaoka.
2000.
Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice.
J. Virol.
74:5206-5212[Abstract/Free Full Text].
|
| 9.
|
Ito, T.,
Y. Suzuki,
A. Takada,
A. Kawamoto,
K. Otsuki,
H. Masuda,
M. Yamada,
T. Suzuki,
H. Kida, and Y. Kawaoka.
1997.
Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection.
J. Virol.
71:3357-3362[Abstract].
|
| 10.
|
Kawaoka, Y.,
S. Krauss, and R. G. Webster.
1989.
Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics.
J. Virol.
63:4603-4608[Abstract/Free Full Text].
|
| 11.
|
Kobasa, D.,
M. E. Rodgers,
K. Wells, and Y. Kawaoka.
1997.
Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks.
J. Virol.
71:6706-6713[Abstract].
|
| 12.
|
Lamb, R. A., and R. M. Krug.
1996.
Orthomyxoviridae: the viruses and their replication, p. 1353-1395.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 13.
|
Laver, W. G., and R. G. Webster.
1973.
Studies on the origin of pandemic influenza. III. Evidence implicating duck and equine influenza viruses as possible progenitors of the Hong Kong strain of human influenza.
Virology
51:383-391[CrossRef][Medline].
|
| 14.
|
Liu, C., and G. M. Air.
1993.
Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase genes.
Virology
194:403-407[CrossRef][Medline].
|
| 15.
|
Liu, C.,
M. C. Eichelberger,
R. W. Compans, and G. M. Air.
1995.
Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding.
J. Virol.
69:1099-1106[Abstract].
|
| 16.
|
Mitnaul, L. J.,
M. Matrosovich,
M. R. Castrucci,
A. B. Tuzikov,
N. V. Bovin,
D. Kobasa, and Y. Kawaoka.
2000.
Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus.
J. Virol.
74:6015-6020[Abstract/Free Full Text].
|
| 17.
|
Neumann, G.,
T. Watanabe,
H. Ito,
S. Watanabe,
H. Goto,
P. Gao,
M. Hughes,
D. R. Perez,
R. Donis,
E. Hoffmann,
G. Hobom, and Y. Kawaoka.
1999.
Generation of influenza A viruses entirely from cloned cDNAs.
Proc. Natl. Acad. Sci. USA
96:9345-9350[Abstract/Free Full Text].
|
| 18.
|
Palese, P.,
K. Tobita,
M. Ueda, and R. W. Compans.
1974.
Characterization of temperature-sensitive influenza virus mutants defective in neuraminidase.
Virology
61:397-410[CrossRef][Medline].
|
| 19.
|
Ray, M. K.,
J. Yang,
S. Sundaram, and P. Stanely.
1991.
A novel glycosylation phenotype expressed by lec23, a Chinese hamster ovary mutant deficient in alpha-glucosidase I.
J. Biol. Chem.
266:18-25.
|
| 20.
|
Rogers, G. N., and J. C. Paulson.
1983.
Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin.
Virology
127:361-373[CrossRef][Medline].
|
| 21.
|
Rogers, G. N.,
T. J. Prichett,
J. L. Lane, and J. C. Paulson.
1983.
Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants.
Virology
131:394-408[CrossRef][Medline].
|
| 22.
|
Scholtissek, C.,
W. Rohde,
V. von Hoyningen, and R. Rott.
1978.
On the origin of the human influenza virus subtypes H2N2 and H3N2.
Virology
87:13-20[CrossRef][Medline].
|
| 23.
|
Shibata, S.,
F. Yamamoto-Goshima,
K. Maeno,
T. Hanaichi,
Y. Fujita,
K. Nakajima,
M. Imai,
T. Komatsu, and S. Sugiura.
1993.
Characterization of a temperature-sensitive influenza B virus mutant defective in neuraminidase.
J. Virol.
67:3264-3273[Abstract/Free Full Text].
|
| 24.
|
Shibuya, N.,
I. J. Goldstein,
W. F. Broekaert,
M. Nsimba-Lubaki,
B. Peeters, and W. J. Peumans.
1987.
The elderberry (Subbucus nigra L.) bark lectin recognizes the Neu5(alpha 2-6)Gal/GalNAc sequence.
J. Biol. Chem.
262:1596-1601[Abstract/Free Full Text].
|
| 25.
|
Suzuki, T.,
G. Horiike,
Y. Yamazaki,
K. Kawabe,
H. Masuda,
D. Miyamoto,
M. Masuta,
S. I. Nishimura,
T. Yamagata,
T. Ito,
H. Kiha,
Y. Kawaoka, and Y. Suzuki.
1997.
Swine influenza virus strains recognize sialylsugar chains containing the molecular species of sialic acid predominantly present in the swine tracheal epithelium.
FEBS Lett.
404:192-196[CrossRef][Medline].
|
| 26.
|
Wang, W. C., and R. D. Cummings.
1988.
The immobilized leukoagglutinin from the seeds of Maackia amurensis binds with high affinity to complex-type Asn-linked oligosaccharides containing terminal sialic acid-linked -2,3 to penultimate galactose residues.
J. Biol. Chem.
263:4576-4585[Abstract/Free Full Text].
|
| 27.
|
Webster, R. G.,
W. J. Bean,
O. T. Gorman,
T. M. Chambers, and Y. Kawaoka.
1992.
Evolution and ecology of influenza A viruses.
Microbiol. Rev.
56:152-179[Abstract/Free Full Text].
|
| 28.
|
Wiley, D. C., and J. J. Skehel.
1987.
The structure and function of the hemagglutinin membrane glycoprotein of influenza virus.
Annu. Rev. Biochem.
56:3665-394.
|
| 29.
|
Yang, P.,
A. Bansal,
C. G. Liu, and G. M. Air.
1997.
Hemagglutinin specificity and neuraminidase coding capacity of neuraminidase-deficient influenza viruses.
Virology
229:155-165[CrossRef][Medline].
|
Journal of Virology, April 2001, p. 3766-3770, Vol. 75, No. 8
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.8.3766-3770.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Shinya, K., Fujii, Y., Ito, H., Ito, T., Kawaoka, Y.
(2004). Characterization of a Neuraminidase-Deficient Influenza A Virus as a Potential Gene Delivery Vector and a Live Vaccine. J. Virol.
78: 3083-3088
[Abstract]
[Full Text]
-
Gubareva, L. V., Nedyalkova, M. S., Novikov, D. V., Murti, K. G., Hoffmann, E., Hayden, F. G.
(2002). A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site. J. Gen. Virol.
83: 2683-2692
[Abstract]
[Full Text]